Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-090052

Chief Executive Officer gave up 259,583 shares (to pay taxes)

  • Chief Executive Officer acquired 450,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2024-07-31 Option exercise +450,000 $3.29 $1,480,500 798,811 D: show line 1 in the form
BELANOFF JOSEPH K Chief Executive Officer 2024-07-31 Shares withheld for taxes −259,583 $38.67 $10,038,075 539,228 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2024-07-31 Option exercise · Stock option (right to buy) −450,000 0 D: show line 3 in the form
Loading xslF345X05/ownership.xml…